Variant report
Variant | esv3487341 |
---|---|
Chromosome Location | chr12:56002150-56004349 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr12:56003640-56003703 | GM13977 | blood: | n/a | n/a |
2 | EBF1 | chr12:56002266-56002267 | GM12878 | blood: | n/a | n/a |
3 | RUNX3 | chr12:56002050-56002330 | GM12878 | blood: | n/a | n/a |
4 | RUNX3 | chr12:56002019-56002332 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR6U2P | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567171840 | chr12:56002225-56002226 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs528040673 | chr12:56002229-56002230 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs372684493 | chr12:56002232-56002233 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs73327966 | chr12:56002233-56002234 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs530196449 | chr12:56002253-56002254 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs201209895 | chr12:56002280-56002281 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs75763754 | chr12:56002303-56002304 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs567883591 | chr12:56002335-56002336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs538034257 | chr12:56002342-56002343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs142639901 | chr12:56002491-56002492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575910930 | chr12:56002520-56002521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs71459306 | chr12:56002595-56002596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs6581073 | chr12:56002614-56002615 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs538650115 | chr12:56002629-56002630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553796006 | chr12:56002659-56002660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551957447 | chr12:56002698-56002699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112731462 | chr12:56002730-56002731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555349595 | chr12:56002737-56002738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs150590463 | chr12:56002746-56002747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573798849 | chr12:56002831-56002832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs139548843 | chr12:56002869-56002870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149717212 | chr12:56002888-56002889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577767838 | chr12:56002896-56002897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs374627156 | chr12:56002971-56002972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs61217209 | chr12:56002972-56002973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs12229232 | chr12:56002973-56002974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532111349 | chr12:56002974-56002975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs200730066 | chr12:56002975-56002976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs111428368 | chr12:56002990-56002991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs187788419 | chr12:56002993-56002994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527277665 | chr12:56002994-56002995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs71446512 | chr12:56002997-56002998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192407889 | chr12:56003685-56003686 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Seminomas | 18059402 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 18632612 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Melanoma | 18172304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Bladder cancer | 21909424 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 17661082 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 20531469 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Glioblastoma multiforme | 21569311 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:56001200-56003000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr12:56001400-56002200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr12:56001800-56002400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr12:56001800-56002800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr12:56001800-56002800 | Enhancers | HMEC | breast |
6 | chr12:56002000-56002400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr12:56002000-56002400 | Enhancers | NHEK | skin |